BB&T Securities’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,036
Closed -$269K 1705
2019
Q2
$269K Sell
1,036
-192
-16% -$50.9K ﹤0.01% 1369
2019
Q1
$350K Sell
1,228
-2
-0.2% -$665 ﹤0.01% 1227
2018
Q4
$399K Buy
1,230
+264
+27% +$91.7K ﹤0.01% 1064
2018
Q3
$434K Buy
966
+38
+4% +$15K ﹤0.01% 1150
2018
Q2
$379K Sell
928
-382
-29% -$138K ﹤0.01% 1185
2018
Q1
$381K Buy
1,310
+138
+12% +$35K ﹤0.01% 1141
2017
Q4
$219K Buy
+1,172
New +$219K ﹤0.01% 1311
2017
Q3
Sell
-4,154
Closed -$595K 1470
2017
Q2
$595K Buy
4,154
+43
+1% +$5.78K 0.01% 921
2017
Q1
$514K Sell
4,111
-111
-3% -$12.9K 0.01% 876
2016
Q4
$542K Hold
4,222
0.01% 809
2016
Q3
$542K Sell
4,222
-99
-2% -$11.9K 0.01% 808
2016
Q2
$472K Sell
4,321
-64
-1% -$6.37K 0.01% 822
2016
Q1
$415K Buy
4,385
+12
+0.3% +$1.01K 0.01% 832
2015
Q4
$394K Buy
4,373
+266
+6% +$22.6K 0.01% 811
2015
Q3
$380K Buy
4,107
+36
+0.9% +$3.17K 0.01% 788
2015
Q2
$267K Buy
4,071
+71
+2% +$4.72K 0.01% 943
2015
Q1
$286K Buy
+4,000
New +$217K 0.01% 895

Other funds holding ABMD

BB&T Securities's ABMD Position: Q3 2019 in Review

BB&T Securities sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,036 shares — an estimated $269K sold.

BB&T Securities first reported a position in ABMD in Q1 2015 and held it in 17 quarters. The position peaked at $595K in Q2 2017. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • BB&T Securities reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • BB&T Securities sold 1,036 Abiomed Inc shares in Q3 2019, an estimated $269K.
  • BB&T Securities first reported a position in Abiomed Inc in Q1 2015 and held it in 17 quarters.
  • BB&T Securities's Abiomed Inc position peaked at $595K in Q2 2017.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.